Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.
Clinical trial NCT06720662 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06720662
- Sponsor
- University of Sao Paulo
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2025-12-30
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.